Publications

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan DE, Vogel A, Yarchoan M, Finn RS, Meyer T, Singal AG. Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement. Nature reviews. Clinical oncology. 2026. PMID: 42270817

Mennillo E, Lotstein ML, Lee G, Hou JH, Johri V, Leet DE, Ekstrand CA, Tsui J, He JY, Mahadevan U, Eckalbar WL, Gill RM, Bowman CJ, Oh DY, Fragiadakis GK, Kattah MG, Combes AJ. Single-cell spatial transcriptomics of formalin-fixed, paraffin-embedded biopsies reveals colitis-associated cell networks. The Journal of clinical investigation. 2026. PMID: 42262875

Zeng J, Cheng Z, Chen H, Wang Z, Thompson J, Crosby KT, Han H, Singhal A, Ngo W, Xia C, Rosas-Rivera D, Zhang Z, Kang MH, Mao Y, Diolaiti ME, Lee GC, Diffley JFX, Song Y, Qiu L, Krah NM, Murthy N, Jackson RN, Liu Y, Ashworth A, Doudna JA. Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding. Nature. 2026. PMID: 42259916

Lipof J, Bloudek B, Ray A, Ting J, Hasegawa K, Gong C, Williams T, Ramsey S, Chari A. Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model. Clinical lymphoma, myeloma & leukemia. 2026. PMID: 42342528

Gu D, Cuby J, Gomez O, Mark H, Hall S, Stitzer M, Kushel M, Vijayaraghavan M. Money Helps: Financial Incentives for Smoking Cessation Among People Experiencing Homelessness. Substance use & misuse. 2026. PMID: 42246249

Wong P, Pollini T, Hernandez S, Tao S, Qiao G, Amouzegar A, Bol GM, Daud AI, Tao DL, Tsai KK, Lee J, Maker AV. The paradox of escalating immunotherapy for uveal melanoma liver metastases. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2026. PMID: 42315386

Rugo HS, Curigliano G, Cescon DW, Penault-Llorca F, Harbeck N, Im SA, Park YH, Barrios C, Modi S, Tolaney SM, Oliveira M. New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice. Breast (Edinburgh, Scotland). 2026. PMID: 42263382

Harris CS, Tsai KK, Liu L, Oppegaard KR, Cooper BA, Paul SM, Hubbard EM, Levine JD, Miaskowski CA. Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma. Nursing research. 2026. PMID: 42228432

Raleigh D, Cady M, Aggarwal A, Stevers N, Zakimi N, Liu I, Mirchia K, Coukos J, Kongpracha P, Zhou Y, Nguyen M, Braman B, Leclair N, Phillips J, Chow K, Shamdasani-Sen S, Chantousti N, Choi B, Hong C, Toedebusch R, Englander R, Frankus J, Sinha D, Karner H, Rosenbluth J, Veer LV', Choudhury A, Liu SJ, Krogan N, Costello J, Anczuków O, Toedebusch C, Dickinson P, Goodarzi H, Swaney D. A proteogenomic RNA processing mechanism drives sex differences in meningioma. Research square. 2026. PMID: 42282014

Berger JI, Anderson AD, Martinez OV, Morris MI, Raja M, Lekakis LJ, Beitinjaneh A, Jimenez A, Goodman M, Wang TP, Spiegel J, Holtzman NG, Komanduri KV, Pereira D, Green D, Camargo JF. Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience. Cureus. 2026. PMID: 42395230

Chatterjee A, Mustafa Ali MK, Bailey CM, Liu Y, Small D, Smith CC, Traer E, Wang Y, Silvestri G, Baer MR. Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors. Leukemia. 2026. PMID: 42230959

Kennedy VE, Peretz CAC, Walia A, Chyla B, Sun Y, Hill JE, Tran E, Koh AD, Ferng TT, Pintar S, Jones M, Popescu B, Lomeli I, Chehab F, Murad N, John A, Roy RP, Olshen AB, Berryhill CA, Davis C, Angus SP, Rivera JM, Meshulam A, Stieglitz E, Joshi SK, Traer E, Dail M, Hamidi H, Altman JK, Daver NG, Levis MJ, McCloskey J, Perl AE, Smith CC. Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy. Blood. 2026. PMID: 42224378

Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, Bhatia S, Bichakjian C, Boland G, Chandra S, Chen D, Chmielowski B, Choi J, DiMaio D, Dronca R, Fleming MD, Galan A, Guild S, Hu-Lieskovan S, Karakousis G, Kendra K, Kiuru M, Lange JR, Lanning R, Logan T, Materin M, Nelson K, Olson D, Olszanski AJ, Ott PA, Puzanov I, Rothermel L, Salama AK, Shannon A, Sharma R, Singh A, Stacey A, Tsai K, Wuthrick E, Xing Y, McMillian N, Espinosa S. Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 42297031

McConathy J, Koshkin VS, Menda Y, Rodon J, Goenka AH, Moy RH, Morse S, Demange A, Blumenstein L, Babaoglan B, Aimone P, Hope TA. Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42223513

Pollyea DA, Altman JK, Assi R, Bachiashvili K, Bhatt VR, Fathi AT, Fedorov K, Foran JM, Gojo I, Goldberg A, Hall AC, Jonas BA, Levine MR, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, Nejati R, Olin R, Patel A, Percival ME, Perl A, Pettit K, Rao D, Ravandi F, Schwabkey Z, Shallis R, Stahl M, Stone RM, Thota S, Uy GL, Walker A, Wang E, Awotiwon A, Roth SL, Stehman K. NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 42297017

Aggarwal R, Oseran AS, Manrai AK, Marinacci LX, Bhatt DL, Yeh RW, Ho JE, Rodman A, Wadhera RK. Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations. Circulation. 2026. PMID: 42224376

Beumer A, Carlson M, Arcuri AL, Maues J, Cowden J, Walker S, Shanahan K, Collins JL, Veach AJ, Rugo HS, Burkard ME, Kalinsky KM, Bardia A, Lustberg MB, Papautsky EL, Roberson ML. A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer. Journal of Patient Experience. 2026. PMID: 42227000

Malangwa G, Banzi MO, Makupa G, Nnko G, Mwakipunda L, Rugengemanzi E, Karia A, Ramadhan A, Mashashi G, Idrisa C, Gisiri M, Kashabano J, Mabruk NA, Moturi M, Mushi B, Ndumbalo J, Kahesa C, Maunda K, DeBoer RJ, Mmbaga E, Lugina EL. The social and clinical profile of patients with ocular surface squamous cell carcinoma in Tanzania. BMC cancer. 2026. PMID: 42218433

Dent S, Nadler MB, Blaes A, Iqbal A, Ayettey HNG, Alvarez-Cardona J, Chan A, Koh ES, Mascunano RC, George M, Aryeetey NA, Howden EJ, Kazuhiro S, Latif N, Ozaki AF, Semple CJ, Ramalingan T, Iyenger NM, Rugo HS, Koczwara B. Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026. PMID: 42209784

Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Research Communications. 2026. PMID: 42219553